2.2.0.25falsefalse001050 - Disclosure - Adoption of New Accounting Policiestruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 4/3/2011
USD ($)
USD ($) / shares
$Cur_3mos_20110403http://www.sec.gov/CIK0000078003duration2011-01-01T00:00:002011-04-03T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDperShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalse3false0us-gaap_AccountingChangesAndErrorCorrectionsTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div>
<div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left">
<a name="xbrlnote2"><b><u><font style="DISPLAY: inline; TEXT-DECORATION: underline">Note
2. Adoption of New Accounting Policies</font></u></b></a>
</div>
<div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="justify">
 
</div>
<div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left">
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
provisions of the following new accounting standards were adopted as
of January 1, 2011 and did not have a significant impact on our
condensed consolidated financial statements:</font>
</div>
<div style="display: block; text-indent: 0pt">
<br/>
</div>
<div>
<table width="100%" cellspacing="0" cellpadding="0" border="0" align="center" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="width: 18pt">
<div style="text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt">
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">●</font>
</div>
</td>
<td>
<div align="left">
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">New
guidelines that address the recognition and presentation of
the annual fee paid by pharmaceutical companies beginning on
January 1, 2011 to the U.S. Treasury as a result of U.S.
Healthcare Legislation. As a result of adopting this new
standard, we are recording the annual fee ratably throughout
the year in the </font><i><font style="DISPLAY: inline; FONT-STYLE: italic">Selling,
informational and administrative expense</font></i><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">s
line item in our condensed consolidated statement of income.</font>
</div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt">
<br/>
</div>
<div>
<table width="100%" cellspacing="0" cellpadding="0" border="0" align="center" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="width: 18pt">
<div style="text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt">
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">●</font>
</div>
</td>
<td>
<div align="left">
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An
amendment to the guidelines that address the accounting for
multiple-deliverable arrangements to enable companies to
account for certain products or services separately rather
than as a combined unit.</font>
</div>
</td>
</tr>
</table>
</div>
</div>
</div>Note
2. Adoption of New Accounting Policies
 
The
provisions of the following new accountingfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 1.N.Q3)
-URI http://asc.fasb.org/extlink&oid=6369664&loc=d3e30840-122693
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=6368906&loc=d3e21914-107793
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 154
-Paragraph 17, 22, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22499-107794
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 1
-Section N
Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22595-107794
Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22644-107794
falsefalse12Adoption of New Accounting PoliciesUnKnownUnKnownUnKnownUnKnownfalsetrue